IceCure Medical logo
IceCure Medical
ICCM | NASDAQ
Chart Builder DCF Calculator
$0.76
+$0.03 (+4.11%)
At close: Nov 16, 2026, 4:00 PM ET
$0.80
+$0.04 (+5.26%)
After-hours: Nov 16, 2026, 7:43 PM ET

IceCure Medical Company Profile

Company profile explained

Company Profile

Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.

Key Executives

Name Position
Eyal Shamir Chief Executive Officer & Director
Meir Peleg Chief Financial Officer
Shay Levav Chief Operating Officer
Galit Malik Vice President of Operations & Service
Merav Nir Dotan Vice President of Human Resources
Shad Good Vice President of Sales for North America
Tlalit Bussi Tel-Tzure Vice President of Business Development & Global Marketing

Latest SEC Filings

Date Type Title
Oct 13, 2026 6-K Filing
Oct 05, 2026 6-K Filing
Oct 05, 2026 6-K Filing
Sep 28, 2026 6-K Filing
Sep 10, 2026 6-K Filing
Aug 24, 2026 6-K Filing
Aug 18, 2026 EFFECT Filing
Aug 18, 2026 EFFECT Filing
Aug 17, 2026 4 Filing
Aug 17, 2026 3 Filing
View All SEC Filings ➞
IceCure Medical
IceCure Medical logo
Country Israel
IPO Date Aug 26, 2021
Industry Medical - Devices
Sector Healthcare
Employees 68
CEO Eyal Shamir

Contact Details

7 Ha’Eshel Street Caesarea, HA 3079504 Israel

Stock Details

Ticker Symbol ICCM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001584371
CUSIP Number M53071201
ISIN Number IL0011224156
SIC Code 3841

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.